Help
Subscribe


GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy

 25 November 2017

Advanced search
GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy Profile of Roy Pounder

Home

News  
Journals
Review Articles
Slide Atlas
Video Clips
Online Books
Advanced Digestive Endoscopy
Classical Cases
Conference Diary
PubMed
International GH Links
USA GH Links
National GH Links
National GI Societies
Other Useful Links




Emails on Gastroenterology and Hepatology
the National AIDS Treatment Advocacy Project
Visit the gastroenterology section of the EUMS

News

Binge eating and obesity due to melanocortin 4 receptor gene mutations

Two separate teams of researchers in this week's New England Journal of Medicine investigate the influence of melanocortin 4 receptor gene mutations on binge eating and obesity.

News image

fiogf49gjkf04

Melanocortin 4 receptor (MC4R) deficiency is the commonest monogenic form of obesity. However, the clinical spectrum and mode of inheritance have not been defined.

In addition, pathophysiological mechanisms leading to obesity are poorly understood, and there is little information regarding genotype-phenotype correlations.

In this study, researchers from Cambridge, England, determined the nucleotide sequence of the MC4R gene in 500 probands with severe childhood obesity.

All mutation carriers reported binge eating.
New England Journal of Medicine

The research team also undertook family studies to examine cosegregation of identified mutations with obesity.

Subjects with MC4R deficiency underwent metabolic and endocrine evaluation. The team then correlated these results with the signaling properties of mutant receptors.

The researchers found that 6% of probands had mutations in MC4R. Of these, 23 were heterozygous and 6 were homozygous.

The team determined that mutation carriers had severe obesity, increased lean mass, increased linear growth, hyperphagia, and severe hyperinsulinemia. However, homozygotes were more severely affected than heterozygotes.

In addition, they found that subjects with mutations retaining residual signaling capacity had a less severe phenotype.

Dr Sadaf Farooqi's team concluded, "Mutations in MC4R result in a distinct obesity syndrome that is inherited in a codominant manner".

"Mutations leading to complete loss of function are associated with a more severe phenotype."

"The correlation between the signaling properties of these mutant receptors and energy intake emphasizes the key role of this receptor in the control of eating behavior in humans."

In a separate but related article in the same publication, researchers looked at, "Binge eating as a major phenotype of melanocortin 4 receptor gene mutations".

In this study, a team of researchers assessed 469 severely obese white subjects (370 women and 99 men, mean age 41 years, BMI 44.1).

They sequenced the complete MC4R coding region, the region of the proopiomelanocortin gene (POMC) encoding the melanocyte-stimulating hormone, and the leptin-binding domain of LEPR.

In addition, 15 women and 10 men without a history of dieting or a family history of obesity served as normal-weight controls (mean age 47.7 years, BMI 21.6).

The team also collected detailed phenotypic data. This included information on body fat, resting energy expenditure, diet-induced thermogenesis, serum concentrations of leptin, and eating behavior.

The researchers found that 5% of the obese subjects and 4% of the control subjects had MC4R mutations, including 5 novel variants.

They then matched 20 of the 24 obese subjects with an MC4R mutation with 120 of the 445 obese subjects without an MC4R mutation.

The research team found that all mutation carriers reported binge eating. This compared with 14% of obese subjects without mutations, and 0% of the normal-weight subjects without mutations.

The team also determined that the prevalence of binge eating was similar among carriers of mutations in the leptin-binding domain of LEPR and noncarriers.

No mutations were found in the region of POMC encoding melanocyte-stimulating hormone.

Dr Ruth Branson's team, "Binge eating is a major phenotypic characteristic of subjects with a mutation in MC4R, a candidate gene for the control of eating behavior".

New Engl J Med 2003; 348: 1085-95, 1096-103
21 March 2003

Go to top of page Email this page Email this page to a colleague

 24 November 2017 
Osteoporotic fractures in Barrett's esophagus
 24 November 2017 
Center ERCP volume and procedure success
 24 November 2017 
Adipokines and IBD
 23 November 2017 
Pharmacological management of GERD
 23 November 2017 
Incidence of biopsy-verified celiac disease
 23 November 2017 
Distance travelling for rectal cancer outcomes
 22 November 2017 
Challenges of US-trained gastroenterologists when abroad
 22 November 2017 
Surgical treatment delays influence survival in colon cancer
 22 November 2017 
Golimumab in Crohn's disease
 21 November 2017 
Preoperative optimization in IBD patients
 21 November 2017 
Cholangiopathy in critically ill patients
 21 November 2017 
Prepregnancy obesity and maternal mortality
 20 November 2017 
Barriers to hepatitis C treatment
 20 November 2017 
Socioeconomic characteristics in diverticular disease
 20 November 2017 
Endoscopic indices of disease activity for Crohn’s
 17 November 2017 
Food elimination diets for treatment of adults with eosinophilic esophagitis
 17 November 2017 
PPI use and cognitive function in women
 17 November 2017 
Predicting microscopic colitis
 16 November 2017 
NAFLD-hepatocellular carcinoma and survival after orthotopic liver transplant
 16 November 2017 
Prepregnancy obesity and severe maternal morbidity
 16 November 2017 
Celiac disease screening in adult first-degree relatives
 15 November 2017 
Breastfeeding and the risk of IBD
 15 November 2017 
Predicting recurrence after curative rectal cancer surgery
 15 November 2017 
Medication nonadherence and health care costs
 14 November 2017 
Eosinophilic gastroenteritis and colitis
 14 November 2017 
HBV/HCV coinfection and cirrhosis
 14 November 2017 
Sexual dysfunction after rectal cancer surgery
 13 November 2017 
Genetic polymorphisms, fatty acids and ulcerative colitis
 13 November 2017 
Flares after immunomodulator withdrawal in Crohn's
 13 November 2017 
GI bleeding in patients taking non–vitamin K antagonist oral anticoagulants
 10 November 2017 
Thiopurines vs TNF and lymphoma risk in IBD
 10 November 2017 
Drug monitoring of anti-tumour necrosis factor therapy in IBD
 10 November 2017 
Treatment decisions for older patients with colorectal cancer
 09 November 2017 
Quality standards in upper gastrointestinal endoscopy
 09 November 2017 
Irradiated rectal cancer and chemoradiotherapy
 09 November 2017 
Environmental factors and IBD
 08 November 2017 
Prophylaxis of spontaneous bacterial peritonitis
 08 November 2017 
Optimal management of postoperative Crohn's disease
 07 November 2017 
Community Screening for Helicobacter pylori
 07 November 2017 
Early readmission in IBD patients
 07 November 2017 
Mesocolic excision for colon cancer
 06 November 2017 
Food elimination diet for children with eosinophilic esophagitis
 06 November 2017 
Biologic agents and obesity in children with IBD
 06 November 2017 
Liver cancer burden despite extensive use of antiviral agents
 03 November 2017 
Statins and mortality in chronic viral hepatitis
 03 November 2017 
Propofol for outpatient colonoscopy
 03 November 2017 
Asthma and IBD development
 02 November 2017 
Diverticulitis and emergency department burden
 02 November 2017 
Rural residence and risk of IBD
 02 November 2017 
Sexual functioning in Hep C
 01 November 2017 
Autoimmune pancreatitis in children
 01 November 2017 
Heartburn relief in adolescents with GERD
 31 October 2017 
Follow-up of positive results on fecal blood tests
 31 October 2017 
Surveillance in ulcerative colitis and Crohn’s disease
 30 October 2017 
Local recurrence after curative rectal cancer surgery
 30 October 2017 
Low-flow ascites pump in refractory cirrhosis
 30 October 2017 
Medical therapy of patients with pediatric-onset IBD
 27 October 2017 
NAFLD in advanced fibrosis in the USA
 27 October 2017 
Early readmission in cirrhosis after bacterial infections
 26 October 2017 
Predicting response to anti-TNF therapy in Crohn's

Blackwell Publishing


GastroHep.com is a Blackwell Publishing registered trademark
© 2017 Wiley-Blackwell and GastroHep.com and contributors
Privacy Statement
Disclaimer
About Us